background
two
recent
discov
polyomavirus
pyv
wu
ki
identifi
respiratorytract
specimen
children
acut
respiratori
infect
although
limit
data
hivinfect
children
object
determin
preval
clinic
manifest
wupyv
kipyvassoci
lower
respiratori
tract
infect
lrti
hospit
hivinfect
uninfect
children
probe
role
pneumococc
coinfect
studi
design
nasopharyng
aspir
collect
cohort
children
random
receiv
pneumococc
conjug
vaccin
placebo
hospit
lrti
screen
pcr
wupyv
kipyv
respiratori
virus
result
placeborecipi
preval
wupyv
hivinfect
hivuninfect
children
p
wupyvposit
lrti
hivinfect
children
lower
oxygen
satur
admiss
higher
case
fatal
rate
vs
p
kipyv
identifi
hivinfect
hivuninfect
placeborecipi
lrti
p
hivinfect
compar
hivuninfect
children
kipyvposit
lrti
lower
oxygen
satur
higher
respiratori
rate
longer
durat
hospit
coinfect
respiratoryvirus
detect
wupyvposit
lrti
kipyvposit
lrti
among
hivuninfect
children
lower
incid
hospit
clinic
pneumonia
episod
kipyv
ci
wupyv
ci
identifi
among
compar
placeborecipi
conclus
polyomavirus
commonli
identifi
hivinfect
uninfect
children
hospit
lrti
frequent
associ
virus
may
contribut
pathogenesi
pneumococc
pneumonia
lower
respiratori
tractinfect
lrti
major
caus
hospit
childhood
determin
pathogen
specif
causal
lrti
hamper
lack
sensit
method
diagnos
bacteri
pneumonia
well
concurr
identif
multipl
respiratoryvir
pathogen
particularli
use
molecular
assay
nevertheless
worldwid
studi
attribut
larg
proport
lrti
viral
infect
largescal
molecular
screen
base
technolog
contribut
discoveri
new
infecti
pathogen
includ
two
polyomavirus
pyv
wuand
kipolyomaviru
pyv
belong
polyomavirida
famili
associ
respiratori
diseas
human
although
direct
evid
causal
lack
two
polyomavirus
bkpyv
jcpyv
implic
diseas
immunocompromis
patient
howev
conflict
data
regard
role
wupyv
kipyv
immunocompromis
individu
previou
studi
use
pneumococcalconjugatevaccin
pcv
random
placebocontrol
trial
rct
probe
establish
probabl
coinfect
streptococcu
pneumonia
pneumococcu
vaccineserotyp
respiratoryviru
children
hospit
pneumonia
ration
approach
biologicalplaus
differ
pcvand
placeborecipi
incid
diseas
could
associ
vaccineserotyp
pneumococc
infect
would
indic
role
vaccineserotyp
outcom
interest
review
exampl
previous
report
pcvrecipi
lower
incid
pneumonia
hospit
influenzaviru
identifi
conclud
least
similar
proport
influenzaassoci
pneumonia
among
placeborecipi
precipit
coinfect
pcvserotyp
aim
studi
determin
burden
clinic
featur
wupyv
kipyv
infect
hivinfect
hivuninfect
children
hospit
lrti
furthermor
exploratori
analysi
use
design
rct
pcv
probe
whether
pneumococc
coinfect
may
contribut
hospit
pyvassoci
pneumonia
analyz
respiratori
specimen
collect
children
particip
rct
south
africa
previous
describ
briefli
children
random
receiv
dose
placebo
hospitalbas
surveil
allcaus
hospit
undertaken
hospit
children
underw
hiv
test
nasopharyng
aspir
npa
obtain
children
hospit
lrti
identif
select
respiratoryvirus
archiv
februari
onward
studi
npa
collect
februari
januari
children
year
old
analyz
child
recurr
lrti
hospit
npa
collect
day
apart
includ
analysi
sampl
previous
investig
respiratori
syncyti
viru
rsv
influenza
ab
parainfluenza
virus
piv
adenoviru
use
immunofluoresc
humanmetapneumoviru
hmpv
nestedpcr
describ
archiv
npa
test
realtim
revers
transcriptasepcr
rrtpcr
use
primer
probe
describ
test
wuand
kipolyomaviru
well
humanbocaviru
hbov
humanrhinoviru
hrv
four
humancoronavirus
cov
comprehens
overview
identifi
individu
virus
report
separ
current
analysi
detail
epidemiolog
wupyv
kipyvposit
lrti
studi
cohort
clinic
definit
use
studi
describ
analys
epidemiolog
wupyv
kipyv
children
hospit
lrti
restrict
placeborecipi
context
initi
trial
proport
compar
chisquar
fisher
exact
test
continu
variabl
student
ttest
mannwhitney
test
regress
analys
perform
compar
clinic
featur
hivinfect
uninfect
children
multipl
regress
control
age
hospit
detect
viru
previouslytest
year
collect
exploratori
analysi
use
concept
vaccineprob
studi
explor
whether
associ
risk
hospit
lrti
wupyv
kipyv
detect
estim
vaccin
efficaci
base
formula
incid
rate
unvaccin
incid
rate
vaccin
incid
rate
unvaccin
children
includ
perprotocol
analysi
receiv
studyvaccin
per
plan
schedul
lrti
event
occur
day
third
dose
studyvaccin
first
episod
viral
detect
includ
calcul
individu
particip
pvalu
consid
signific
analys
perform
use
stata
version
colleg
station
tx
usa
total
npa
analyz
rrtpcr
includ
placeborecipi
wupyv
detect
less
frequent
hivinfect
compar
hivuninfect
children
p
tabl
one
hivinfect
three
hivuninfect
children
least
two
episod
wupyvposit
lrti
day
apart
among
hivuninfect
children
wupyv
gener
detect
concurr
respiratoryvirus
higher
frequenc
compar
hivinfect
children
p
tabl
common
codetect
virus
hrv
n
hbov
n
rsv
n
hmpv
n
hivuninfect
children
hrv
n
kipyv
n
hivinfect
children
multivari
analysi
wupyvassoci
lrti
hivinfect
compar
hivuninfect
children
like
oxygen
satur
present
clinicallya
pneumonia
f
laboratori
investig
assess
significantli
differ
hivinfect
hivuninfect
children
includ
percentag
children
present
creactiv
protein
level
mgl
procalcitonin
level
ngml
mean
white
cell
count
g
streptococcu
pneumonia
isol
one
hivinfect
child
two
hivuninfect
children
wupyv
detect
h
bacteria
isol
hivinfect
children
kipyv
detect
includ
streptococcu
pneumonia
n
escherichia
coli
n
haemophilu
parainfluenza
n
rather
bronchiol
pneumococci
isol
blood
cultur
one
hivinfect
child
two
hivuninfect
children
wupyvassoci
lrti
tabl
hivinfect
compar
hivuninfect
children
p
higher
case
fatal
rate
cfr
two
hivinfect
children
die
month
old
present
pneumonia
wupyv
respiratoryviru
identifi
neither
evid
bacteraemia
pulmonari
tuberculosi
one
child
test
pneumocysti
jiroveci
pcp
infect
neg
tabl
kipyv
detect
specimen
avail
hivinfect
hivuninfect
children
p
tabl
recurr
kipyvassoci
lrti
episod
occur
five
hivinfect
children
includ
three
children
two
episod
one
child
episod
one
child
episod
singl
hivuninfect
child
two
kipyvposit
lrti
identif
kipyv
perenni
albeit
uncommon
novemb
decemb
fig
lower
preval
kipyv
detect
compar
among
hivinfect
kipyv
frequent
detect
combin
respiratoryvirus
hivinfect
hivuninfect
children
tabl
hivinfect
common
codetect
virus
includ
hrv
n
wupyv
hmpv
n
hivuninfect
common
virus
associ
kipyv
hrv
n
hmpv
n
wupyv
n
hivinfect
compar
hivuninfect
children
kipyvassoci
lrti
like
oxygen
satur
higher
respiratori
rate
longer
durat
hospit
median
rang
day
vs
day
p
like
alveolar
consolid
chest
xray
cxrac
concurr
bacteraemia
tabl
pneumococci
isol
three
hivinfect
children
four
hivinfect
two
hivuninfect
children
kipyv
detect
die
hospit
hivuninfect
children
kipyvassoci
lrti
die
compar
surviv
younger
vs
month
p
hivuninfect
children
age
month
present
pneumonia
coinfect
virus
one
child
malnourish
also
pcp
infect
tabl
four
hivinfect
children
die
kipyv
respiratoryviru
identifi
two
although
least
one
coinfect
pcp
overal
five
six
children
die
indirect
marker
bacteri
infect
includ
three
hivinfect
rais
creactiv
protein
procalcitonin
level
two
also
escherichia
coli
bacteraemia
two
one
hivinfect
one
hivuninfect
cxrac
tabl
exploratori
analysi
effect
incid
polyomavirusassoci
pneumonia
hospit
evalu
fulli
vaccin
hivuninfect
children
incid
wupyvposit
clinic
pneumonia
hospit
ci
lower
children
receiv
compar
placeborecipi
tabl
similar
pointestim
observ
case
restrict
episod
wupyv
sole
detect
viru
ci
also
reduct
incid
hospit
kipyvassoci
clinic
pneumonia
compar
placeborecipi
overal
ci
specif
hivuninfect
children
ci
similar
reduct
observ
kipyv
identifi
viru
tabl
differ
incid
observ
placeborecipi
hospit
wupyvor
kiassoci
clinic
pneumonia
hivinfect
children
hospit
wupyvor
kipyvassoci
bronchiol
knowledg
detail
report
preval
clinic
featur
lrti
polyomavirus
detect
hivinfect
uninfect
children
among
hospit
hivinfect
children
wupyv
detect
case
kipyv
hivuninfect
children
preval
wupyv
kipyv
hivinfect
children
case
posit
least
one
polyomaviru
fatal
case
total
wupyv
kipyv
identifi
singledetect
studi
also
establish
possibl
interact
polyomavirus
pneumococcu
hivuninfect
children
although
may
mask
hivinfect
children
demonstr
less
efficaci
pneumonia
wupyv
detect
respiratori
sampl
children
present
upper
lrti
germani
south
korea
south
africa
thailand
kipyv
identifi
children
present
respiratorytract
infect
anoth
studi
south
africa
report
children
lrti
wupyv
kipyv
hivinfect
howev
hivstatu
unknown
case
studi
polyomavirus
tabl
differ
incid
wupyv
kipyvassoci
lower
respiratori
tract
infect
fullyimmun
children
receiv
pneumococc
conjug
vaccin
placebo
recipi
perprotocol
analysi
absent
among
healthi
immunocompet
control
role
wukipyv
seriou
pathogen
immunocompromis
individu
uncertain
higher
viral
load
pyv
document
lymphoid
tissu
brain
hivinfect
adult
compar
immunocompet
individu
similarli
higher
kipyv
viral
load
found
respiratorytract
specimen
haematologyoncolog
paediatr
patient
respiratori
infect
howev
whether
viral
load
correl
diseas
sever
establish
observ
suggest
may
viral
replic
andor
polyomavirus
might
reactiv
immunosuppress
individu
impli
tcell
impair
might
factor
facilit
polyomaviru
replic
norja
et
al
found
wukipyv
detect
respiratori
sampl
occur
predominantli
two
group
subject
immunocompet
year
age
lrti
high
frequenc
coinfect
among
older
gener
immunocompromis
individu
without
respiratori
ill
mild
upper
respiratorytract
infect
although
studi
design
establish
whether
polyomaviru
infect
caus
sever
diseas
hivinfect
children
among
hospit
children
polyomavirus
detect
hivinfect
like
present
pneumonia
rather
bronchiol
longer
durat
hospit
higher
cfr
compar
hivuninfect
children
similar
observ
detect
hivinfect
hivuninfect
children
virus
consequ
may
necessarili
infer
causal
polyomavirus
precipit
sever
ill
hivinfect
children
increas
morbid
mortal
hivinfect
children
could
relat
comorbid
bacteri
nonvir
coinfect
absenc
sensit
tool
diagnos
bacteri
pneumonia
well
lack
investig
nonvir
caus
pneumonia
studi
unabl
conclud
actual
role
polyomavirus
sever
diseas
hivinfect
children
nonetheless
higher
cfr
well
four
fatal
case
polyomaviru
sole
respiratoryviru
detect
hivinfect
children
suggest
possibl
associ
polyomaviru
caus
sever
diseas
hivinfect
furthermor
five
hivinfect
children
recurr
kipyvposit
lrti
compar
one
hivuninfect
child
could
due
extend
viral
shed
viral
reactiv
reinfect
studi
germani
detect
kipyv
dna
respiratorytract
immunocompromis
child
month
hypothes
kipyv
infect
childhood
could
result
latenc
viru
normal
individu
howev
immun
impair
could
result
viral
reactiv
detect
rate
kipyv
hivinfect
children
higher
may
older
cohort
henc
possibl
differ
risk
infect
differ
yeartoyear
epidem
concept
vaccineprob
analysi
initi
use
attribut
contribut
haemophilu
influenzatyp
b
aetiolog
radiologicalconfirm
pneumonia
well
subsequ
pcv
trial
use
approach
probe
likelihood
coinfect
children
hospit
pneumonia
associ
influenza
viru
piv
hmpv
demonstr
children
hospit
pneumoniaassoci
virus
like
pneumococcu
coinfect
use
type
analysi
studi
suggest
coinfect
contribut
hospit
clinic
pneumonia
wukipyv
identifi
imput
rate
coinfect
pneumococci
children
polyomavirusesposit
pneumonia
studi
provid
conserv
estim
possibl
interact
serotyp
includ
vaccin
even
vaccineserotyp
pneumococc
pneumonia
high
estim
kipyvposit
diseas
need
contextu
within
wide
uncertainti
bound
estim
suggest
interact
polyomavirus
pneumococcu
warrant
studi
high
coinfect
rate
respiratoryvirus
found
wupyv
kipyv
similar
previou
report
absenc
control
group
children
without
lrti
definit
causal
relationship
polyomaviru
detect
diseas
could
infer
constitut
limit
studi
anoth
limit
studi
reli
npa
identif
organ
necessarili
impli
infect
also
studi
hivinfect
children
treat
antiretrovir
treatment
art
may
contribut
clinic
cours
may
differ
hivinfect
children
treat
art
determin
aetiolog
pneumonia
remain
challeng
especi
children
pathogen
potenti
newlydescrib
respiratoryvirus
difficult
address
context
multipl
infect
without
specif
symptom
although
polyomavirus
frequent
detect
children
hospit
lrti
studi
studi
includ
autopsi
sampl
fatal
lrti
case
lung
aspir
antmortem
also
enrol
healthi
control
requir
clarifi
role
polyomavirus
pathogenesi
pneumonia
